Psychiatric Services
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Lyon, E. R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Lyon, E. R.
Related Collections
* Nicotine
* Schizophrenia Spectrum Disorders
Psychiatr Serv 50:1346-1350, October 1999
© 1999 American Psychiatric Association


Article

A Review of the Effects of Nicotine on Schizophrenia and Antipsychotic Medications

Edward R. Lyon, M.S., Ed.D.

OBJECTIVE: Research on the impact of nicotine on schizophrenia and antipsychotic medications was reviewed to determine ways to improve treatment planning for patients with schizophrenia who smoke and to evaluate smoking cessation programs for this population. METHODS: All major research databases were searched. The review focuses on reports published since 1990. RESULTS: Smoking improves processing of auditory stimuli (sensory gating) by patients with schizophrenia and may lessen negative symptoms by increasing dopamine in the nucleus accumbens and the prefrontal and frontal cortex. Use of traditional antipsychotics may result in patients' smoking more, whereas patients taking atypical antipsychotics may smoke less. Patients who smoke metabolize antipsychotics faster than nonsmoking patients. Smoking cessation programs for outpatients with schizophrenia report a success rate of about 12 percent after six months. No studies of cessation programs for chronically ill inpatients with schizophrenia have been published. Several hospitals have implemented smoking bans with equivocal results. CONCLUSIONS: Nicotine affects both schizophrenia and antipsychotic medications. Neurobiological and psychosocial factors reinforce the high use of nicotine by patients with schizophrenia




This article has been cited by other articles:


Home page
CMAJHome page
P. M. Smith and E. Burgess
Smoking cessation initiated during hospital stay for patients with coronary artery disease: a randomized controlled trial
Can. Med. Assoc. J., June 23, 2009; 180(13): 1297 - 1303.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
J O Goldberg and J Van Exan
Longitudinal rates of smoking in a schizophrenia sample
Tob. Control, August 1, 2008; 17(4): 271 - 275.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
N. el-Guebaly, J. Cathcart, S. Currie, D. Brown, and S. Gloster
Public Health and Therapeutic Aspects of Smoking Bans in Mental Health and Addiction Settings
Psychiatr Serv, December 1, 2002; 53(12): 1617 - 1622.
[Abstract] [Full Text] [PDF]


Home page
Psychiatr. Serv.Home page
N. el-Guebaly, J. Cathcart, S. Currie, D. Brown, and S. Gloster
Smoking Cessation Approaches for Persons With Mental Illness or Addictive Disorders
Psychiatr Serv, September 1, 2002; 53(9): 1166 - 1170.
[Abstract] [Full Text] [PDF]


Home page
J Am Psychiatr Nurses AssocHome page
J. K. Cataldo and S. Talley
Helping Our Clients With Smoking Cessation
Journal of the American Psychiatric Nurses Association, February 1, 2001; 7(1): 26 - 31.
[PDF]


Home page
Psychiatr. Serv.Home page
A. Lucksted, L. B. Dixon, and J. B. Sembly
A Focus Group Pilot Study of Tobacco Smoking Among Psychosocial Rehabilitation Clients
Psychiatr Serv, December 1, 2000; 51(12): 1544 - 1548.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org